Prospective, Multicenter, Non-randomized, Single Arm Clinical Trial to Evaluate the Safety and Efficacy of e-PTFE Grafts Inner Surface-treated With Paclitaxel as an Access for Hemodialysis in Patients With End-stage Renal Disease.

Inclusion Criteria: * Adult male or female between the ages of 20 and 80 * Patients currently undergoing or scheduled for hemodialysis due to end-stage kidney disease. * Patients who decided to receive AVG procedure in forearm due to inability to perform autologous arteriovenous fistula (AVF) * Patients with a high risk of stenosis (neointimal hyperplasia) or thrombosis when artificial blood vessels were implanted Exclusion Criteria: * Pregnant or lactating women * Patients who are currently diagnosed with malignant tumors and are receiving chemotherapy or radiotherapy * Patients with life expectancy less than 12 months * Patients expected to receive a kidney transplant during the trial * Patients with current or suspected infection * Acute psychiatric problems require treatment * Patients who have inserted a catheter into an artery or vein in their upper limb for AVG procedure within the last 30 days * Patients with coagulation disorder, platelet count \<50,000 / Ul * Patients with a neutrophil count of less than 1,500 cells / mm3 * Patients judged to be unable to insert grafts by the operator